UPDATE: Ladenburg Thalmann Downgrades Novus Therapeutics, Inc (NVUS) to Neutral
Tweet Send to a Friend
(Updated - June 2, 2020 6:48 AM EDT)
(updated to add analyst comments)Ladenburg Thalmann analyst Michael Higgins downgraded Novus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)Ladenburg Thalmann analyst Michael Higgins downgraded Novus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
